Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
23 hedge funds and large institutions have $9.54M invested in Psychemedics Corporation in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
10% more funds holding
Funds holding: 21 → 23 (+2)
0% less capital invested
Capital invested by funds: $9.55M → $9.54M (-$12K)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q3 2022 in Review
23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2022, worth a combined $9.54M — down 0.13% from $9.55M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PMD positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $148K. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $276K sold.
- 23 institutional investors held Psychemedics Corporation (PMD) as of Q3 2022, up from 21 in Q2 2022.
- Funds reported $9.54M of Psychemedics Corporation stock for Q3 2022, down 0.13% quarter-over-quarter.
- 3 funds opened new Psychemedics Corporation positions in Q3 2022 and 1 closed out, a net change of +2 holders.
- The largest Psychemedics Corporation buyer in Q3 2022 was Susquehanna International Group, an estimated $148K added.
- The largest Psychemedics Corporation seller in Q3 2022 was Invenomic Capital Management, an estimated $276K sold.
Based on aggregated 13F filings for Q3 2022.